UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

Active surveillance as a treatment strategy in metastatic renal cell carcinoma: Results from a prospective registry in Singapore

European journal of cancer (1990), 2016-06, Vol.60, p.e13-e13

2016

Volltextzugriff (PDF)

Dynamic Contrast-enhanced Magnetic Resonance Imaging: Applications in Oncology

Clinical oncology (Royal College of Radiologists (Great Britain)), 2014-10, Vol.26 (10), p.e9-e20

2014

Volltextzugriff (PDF)

3024 Chemo-radiotherapy in stage III non-small cell lung carcinoma: does the choice of chemotherapy matter?

European journal of cancer (1990), 2015-09, Vol.51, p.S604-S604

2015

Volltextzugriff (PDF)

2872 Pre-treatment EBV DNA and neutrophil-lymphocyte ratio as predictive biomarkers for induction chemotherapy in locally advanced endemic nasopharyngeal carcinoma

European journal of cancer (1990), 2015-09, Vol.51, p.S581-S581

2015

Volltextzugriff (PDF)

A Phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinoma

European journal of cancer (1990), 2013-03, Vol.49 (5), p.999-1008

2013

Volltextzugriff (PDF)

8606 POSTER Optimising Management Approaches for Locally Advanced Oropharyngeal Squamous Cell Carcinoma (LAOPSCC) – a Retrospective Review of Prognostic Factors and Outcomes in an Asian Tertiary Institution

European journal of cancer (1990), 2011, Vol.47, p.S574-S574

2011

Volltextzugriff (PDF)

EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S652-S653

2023

Volltextzugriff (PDF)

201MO Real-world outcome of non-clear cell renal carcinoma patients: A single centre experience from Singapore

Annals of oncology, 2020-11, Vol.31, p.S1320-S1320

2020

Volltextzugriff (PDF)

Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial

Annals of oncology, 2023-03, Vol.34 (3), p.251-261

2023

Volltextzugriff (PDF)

An observational retrospective real-world study of sarcomatoid renal cell carcinoma (sRCC) patients in an Asian cancer centre

Annals of oncology, 2019-11, Vol.30, p.ix72-ix73

2019

Volltextzugriff (PDF)

192P ddPCR versus plasma NGS in detecting clearance of plasma EGFR mutations

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S145

2023

Volltextzugriff (PDF)

P76.46 First-Line Osimertinib in Asian Patients with Advanced EGFR-Mutant Lung Cancer

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S607-S607

2021

Volltextzugriff (PDF)

A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)

Annals of oncology, 2016-12, Vol.27 (12), p.2210-2215

2016

Volltextzugriff (PDF)

P2.09-01 A Large Asian Real-World EGFR exon 20Insertion Mutated NSCLC Dataset with Deep Genomic Characterization

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S330

2023

Volltextzugriff (PDF)

1221P Outcomes of EGFR-mutant NSCLC patients with de novo brain metastases by upfront treatment

Annals of oncology, 2021-09, Vol.32, p.S970-S970

2021

Volltextzugriff (PDF)

266O Combination ipilimumab and nivolumab in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC): Updated efficacy and safety analysis of NCT03097939

Annals of oncology, 2020-11, Vol.31, p.S1347-S1347

2020

Volltextzugriff (PDF)

P2.13-02 Dynamic Tracking of Bespoke Circulating Tumour DNA During Multi-Modality Therapy for Locally Advanced NSCLC (LA-NSCLC)

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S155-S156

2022

Volltextzugriff (PDF)

163P Health-related quality of life (HRQoL) with pembrolizumab (pembro) vs chemotherapy (chemo) in platinum-pretreated recurrent or metastatic (R/M) nasopharyngeal cancer (NPC): Phase III KEYNOTE-122 study

Annals of oncology, 2021-12, Vol.32, p.S1452

2021

Volltextzugriff (PDF)

858O Results of KEYNOTE-122: A phase III study of pembrolizumab (pembro) monotherapy vs chemotherapy (chemo) for platinum-pretreated, recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC)

Annals of oncology, 2021-09, Vol.32, p.S786-S786

2021

Volltextzugriff (PDF)

EP16.03-036 Clinical and Genomic Features of HER2 exon 20 Insertion Mutations in East Asian NSCLC

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S605

2022

Volltextzugriff (PDF)

FP14.13 Molecular Characterisation and Clinical Outcomes in RET Rearranged Non-Small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S233-S233

2021

Volltextzugriff (PDF)

P76.88 Real-World Data of Osimertinib in Patients with Metastatic EGFRm+ NSCLC who Progressed on First-Line EGFR TKIs

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S627-S628

2021

Volltextzugriff (PDF)

P38.03 Immunohistochemical, Histologic and Genomic Characterisation of Early Stage Pulmonary Invasive Mucinous Adenocarcinoma

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S458-S458

2021

Volltextzugriff (PDF)

322P Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (SCC) in Singapore

Annals of oncology, 2015-12, Vol.26, p.ix93-ix93

2015

Volltextzugriff (PDF)

The impact of multi-modality treatment in geriatric patients with unresectable Stage 3 NSCLC

Journal of geriatric oncology, 2023-11, Vol.14 (8), p.S18

2023

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(55)
Tagungsberichte
(1)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Kollektion

EZB Electronic Journals Library
(44)
Journals@OVID
(39)
IngentaConnect
(14)
Access via ScienceDirect (Elsevier)
(12)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(8)
IngentaConnect Journals
(8)
MEDLINE
(7)
IEEE Xplore
(2)

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Active surveillance as a treatment strategy in metastatic renal cell carcinoma: Results from a prospective registry in Singapore

Dynamic Contrast-enhanced Magnetic Resonance Imaging: Applications in Oncology

3024 Chemo-radiotherapy in stage III non-small cell lung carcinoma: does the choice of chemotherapy matter?

2872 Pre-treatment EBV DNA and neutrophil-lymphocyte ratio as predictive biomarkers for induction chemotherapy in locally advanced endemic nasopharyngeal carcinoma

A Phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinoma

8606 POSTER Optimising Management Approaches for Locally Advanced Oropharyngeal Squamous Cell Carcinoma (LAOPSCC) – a Retrospective Review of Prognostic Factors and Outcomes in an Asian Tertiary Institution

EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer

201MO Real-world outcome of non-clear cell renal carcinoma patients: A single centre experience from Singapore

Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial

An observational retrospective real-world study of sarcomatoid renal cell carcinoma (sRCC) patients in an Asian cancer centre

192P ddPCR versus plasma NGS in detecting clearance of plasma EGFR mutations

P76.46 First-Line Osimertinib in Asian Patients with Advanced EGFR-Mutant Lung Cancer

A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)

P2.09-01 A Large Asian Real-World EGFR exon 20Insertion Mutated NSCLC Dataset with Deep Genomic Characterization

1221P Outcomes of EGFR-mutant NSCLC patients with de novo brain metastases by upfront treatment

266O Combination ipilimumab and nivolumab in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC): Updated efficacy and safety analysis of NCT03097939

P2.13-02 Dynamic Tracking of Bespoke Circulating Tumour DNA During Multi-Modality Therapy for Locally Advanced NSCLC (LA-NSCLC)

163P Health-related quality of life (HRQoL) with pembrolizumab (pembro) vs chemotherapy (chemo) in platinum-pretreated recurrent or metastatic (R/M) nasopharyngeal cancer (NPC): Phase III KEYNOTE-122 study

858O Results of KEYNOTE-122: A phase III study of pembrolizumab (pembro) monotherapy vs chemotherapy (chemo) for platinum-pretreated, recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC)

EP16.03-036 Clinical and Genomic Features of HER2 exon 20 Insertion Mutations in East Asian NSCLC

FP14.13 Molecular Characterisation and Clinical Outcomes in RET Rearranged Non-Small Cell Lung Cancer (NSCLC)

P76.88 Real-World Data of Osimertinib in Patients with Metastatic EGFRm+ NSCLC who Progressed on First-Line EGFR TKIs

P38.03 Immunohistochemical, Histologic and Genomic Characterisation of Early Stage Pulmonary Invasive Mucinous Adenocarcinoma

322P Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (SCC) in Singapore

The impact of multi-modality treatment in geriatric patients with unresectable Stage 3 NSCLC

Suchergebnisse filtern